ArcDia International

Cellomatics Biosciences Ltd. (www.cellomaticsbio.com) is a laboratory-based Contract Research Organisation (CRO) specialised in Oncology/Immuno-Oncology, Immunology/Inflammation and Respiratory therapeutic areas.

We provide bespoke pre-clinical/early discovery phase laboratory services to support academic groups, pharmaceutical and biotechnology companies in their R&D studies and biomarker research.

The Company
- Founded in 2015 and Privately owned
- Operating out of Biocity, Nottingham
- Experienced Management team with track record of delivering complex scientific projects and peer reviewed
international publications
- Completed over 40 successful scientific projects in collaboration with over 25 sponsors
- Links with leading UK Universities
- Fully serviced laboratory with Specialised personnel
- National and International partners

Our USP:
- Dynamic CRO offering specialist skills with over 30 years of combined experience
- Therapeutic area expertise
- Value for money
- Efficient time management, thanks to our streamlined structure
- Flexibility in operations to suit our client needs.
- Customised service and support focused on customer retention and satisfaction
- Logistics support

Our vision is 'Integrated scientific services; from experimental conception to project delivery'​.

Our mission is:
- To revolutionise drug discovery research by providing integrated, cost-effective laboratory services including assay design consultancy, logistics support, bespoke high quality assay development/validation and data analysis.
- To be a responsible and trusted laboratory-based CRO partner with Quality, Flexibility, Reliability and Customer support as our indispensable asset.

Humana Biosciences is a pre-clinical Contract Research Organization (CRO) with leading scientific capabilities in Respiratory, Gastro-Intestinal and Uro-Genital therapeutic areas.

Every study we conduct is a custom designed study tailored specifically for the client. Our objective is to offer our customers the best predictive experimental models for chronic functional pathologies.

Our ultimate ambition is to make pre-clinical drug development more predictive and faster. Our mission is to reduce the number of inefficacious candidates moving through to the later stages of clinical investigation by developing innovative experimental models (in vitro and in vivo). Partnering with Humana Biosciences also gives you on-demand access to ethically obtained human tissues.

PamGene is a functional proteomics Company with a unique 3D array platform to measure the ACTIVITY of Tyrosine and Serine/Threonine kinase.

We offer Products (described in our Showcase pages, PamStation-12 ®, Pamchip arrays ® and Reagent kits) and Services (lead optimization, translational/ preclinical research and biomarker discovery). We have developed powerful software tools (BioNavigator) for complex data analysis with which you can interpret results in a biological context. We support clinical trials in the oncology area.

Pamgene is advancing research in Oncology as well as other areas (Neurobiology, Immunology, Metabolic disorders, cardiovascular respiratory diseases). Our technology has a wide range of Applications from fundamental and discovery research to clinical development of therapeutic and diagnostic biomarkers.

Our patented technology stands out in allowing scientists in industry and academia to measure enzyme activity within a cellular context and fully decorated proteins. The assays have high sensitivity, broad kinome coverage and works for many sample sources.

PamGene has a strong science foundation and the number of publications applying our technology continues to rise. PamGene's Customer Service team supports your research with dedication. The PamAcademy offers advanced training, from workflows to data analysis, interpretation and storage. PamGene's PamCloud space allows User-interaction and furthers knowledge exploration.

Please visit our web site for further information (https://www.pamgene.com/) and get in touch with us! (https://www.pamgene.com/en/landing.htm)

Chiesi is an international company originated in Parma, with 85 years of experience and a strong focus on research, development, production and commercialization of innovative therapeutic solutions in the Respiratory, Neonatology, Rare Diseases and Special Care Therapeutic Areas. We are value-oriented, passionate, supportive and a global family with nearly 6.000 employees and 29 affiliates who have a real impact on people's lives in 90 countries around the world. With a turnover of nearly €2 billion sales, we are among the top 50 pharmaceutical companies in the world.
Chiesi is the largest global pharmaceutical Group to be awarded B Corp Certification, a recognition of high social and environmental standards. We want to use business as a force for good and create a positive impact on people, environment and community.

See our community guidelines: https://www.chiesi.com/en/linkedin-community-guidelines/

Crown CRO is a privately owned Finnish CRO founded in 2005. Our headquarters are in Espoo, which is located in Finland’s capital city region. Crown CRO offices are located in Finland, Sweden, Denmark, Norway, Estonia, Latvia and Lithuania. We have ongoing trials managed by our employees in Netherlands, Belgium, UK, Iceland, Ukraine and Belarus. Rest of the Europe and USA we cover through our qualified CRO network.

Our services cover Phase I – IV clinical development from protocol design to final reporting or any parts of the trial in various business models. Data services, Regulatory consulting, Pharmacovigilance, QA, Study Rescue Services and Medical Translation services complete the service package.

Our key therapeutic areas include, but not limited to, CNS, Oncology, Endocrinology, Cardiovascular, Respiratory and Musculoskeletal. We also have strong recent experience in Medical Devices from various indications.

Our passion for research across all our in-house Full-Service functions provide effective and innovative solutions with seamless cooperation for Phase I-III trials in Europe offering special focus on Nordic-Baltic area, together with our own Global Data Services ensuring consistency regardless of where your trials are located, offer you unrivalled customer attention, flexibility and high local level expertise which are key assets you can count on.

See www.crowncro.com for more information.